GLOW Stack
otherGHK-Cu + BPC-157 + TB-500 (commonly discussed)
Stacks & Combinations
Research status · Not FDA-approved
Not an FDA-approved product or standardized medical protocol. Community/vendor formulations and ratios vary, and the included compounds have different evidence and regulatory profiles.
The GLOW Stack commonly refers to a vendor or community combination of GHK-Cu, BPC-157, and TB-500. It is discussed around skin appearance, soft-tissue recovery, and general repair signaling, but it is not a validated or standardized treatment plan.
How it works
This is a combination concept rather than a single mechanism. GHK-Cu is most established as a topical cosmetic peptide, while BPC-157 and TB-500 are unapproved recovery-focused research peptides with limited human evidence.
Commonly discussed purpose
- Skin appearance
- Soft-tissue recovery
- Wellness or repair signaling discussion
Commonly discussed use cases
- Skin appearance (discussed)
- Soft-tissue recovery (discussed)
- General repair signaling (discussed)
Supposed / potential benefits
- Community claims are not proof of clinical benefit
- Any perceived effect should be separated from skincare, rehab, training load, sleep, and time
Common side effects
- Injection-site reactions
- Skin irritation with topical products
- Unknown additive risks when multiple unapproved compounds are combined
Warnings & contraindications
- Educational overview only; not a recommendation to combine these compounds
- Vendor blends may use different ingredients, names, concentrations, or ratios
- Unapproved injectable products carry identity, sterility, purity, and legal risks
Typical timing considerations
No established or recommended regimen. Any clinician-directed use should avoid vendor marketing as a substitute for medical guidance.
Administration route
Varies by component and vendor; topical and injectable forms are discussed
Questions to ask your clinician
- Are any of these components appropriate for my goal, or are conventional options safer?
- How would we verify product identity and avoid unregulated blends?
- What symptom or outcome would justify stopping or changing course?
Commonly tracked in Reta
Tracking fields organize user-entered, clinician-directed routines — Reta never recommends or computes doses.
Track this in Reta
Beta members get a ready-made tracker for GLOW Stack — schedule, dose log, reminders, and check-ins — for organizing a clinician-directed routine. Personal tracking is available to everyone during the Public Beta.
Reta is a tracking and education tool — not a medical provider. Nothing here is a diagnosis, treatment, prescription, or dosing recommendation. Peptides and medications should only be used under the direction of a licensed clinician. Talk to a qualified clinician before starting, stopping, combining, or changing anything. Many compounds below are not FDA-approved for human use; some are investigational or sold through unregulated channels where purity and dosing are not guaranteed.